Merck & Co., Inc. completed the acquisition of Peloton Therapeutics, Inc. from The Column Group LLC.
Catherine J. Dargan, Patrick E. Manchester, Andrew (Drew) Fischer, John Knight, Robert Newman, Erika Skougard, Emily I. Leonard, Asher Hodes, Ansgar A. Simon, Jon Endean, Michael S. Labson, Anna Zhao, Heather G. Haberl, Edward (Ned) Dix, Einar Stole, Jessica S. Milner, Daniel P. Cooper and Marty Myers of Covington & Burling LLP acted as legal advisors and Credit Suisse acted as financial advisor to Merck. Robert Ishii, Kenneth Clark, Tony Jeffries, Jennifer Knapp, Brendan Mahan, Katie Dahlinghaus, Merritt Steele, Miranda Biven, Matt Wiltermuth, Alex Key, Karen Wong, Frank Yang, Brandon Gantus, Matthew Norgard, Myra Sutanto Shen, and Ben Labow of Wilson Sonsini Goodrich & Rosati, P.C. acted as legal advisors and Centerview Partners LLC as financial advisor to Peloton.
Merck & Co., Inc. (NYSE:MRK) completed the acquisition of Peloton Therapeutics, Inc. from The Column Group LLC in July 2019.